Physician profile
Julius E Bunek
NPI 1154659381
$59,743.67
in general payments reported to CMS, 2019-2025
10 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,433 · 2020: $34.33 · 2021: $23K · 2022: $26K · 2023: $4,657 · 2024: $3,369 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,880 · Food and Beverage: $1,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,880.00 |
| Food and Beverage | $1,386.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $32,237.45 | 2019-2022 | |
| Zimvie INC. | $21,174.52 | 2022-2025 | |
| Salvin Dental Specialties, INC. | $5,103.94 | 2021 | |
| Straumann USA LLC | $585.02 | 2019-2023 | |
| Ivoclar Vivadent, INC. | $469.12 | 2019-2024 | |
| Biohorizons Implant Systems INC. | $76.07 | 2019-2025 | Biohorizons Dental Implants |
| Gc America INC. | $38.48 | 2023 | Mipaste One |
| Coltene Whaledent INC. | $30.66 | 2019 | |
| Geistlich Pharma, North America, INC. | $14.75 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $13.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julius Bunek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.